Delta Financial Advisors LLC Sells 36 Shares of The Cigna Group (NYSE:CI)

Delta Financial Advisors LLC reduced its holdings in The Cigna Group (NYSE:CI) by 1.1% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 3,364 shares of the health services provider’s stock after selling 36 shares during the quarter. Delta Financial Advisors LLC’s holdings in The Cigna Group were worth $1,007,000 at the end of the most recent reporting period.

Several other large investors also recently modified their holdings of the business. Bogart Wealth LLC boosted its position in shares of The Cigna Group by 104.5% during the third quarter. Bogart Wealth LLC now owns 90 shares of the health services provider’s stock worth $26,000 after buying an additional 46 shares during the period. OFI Invest Asset Management acquired a new position in The Cigna Group during the third quarter valued at approximately $26,000. Fortitude Family Office LLC acquired a new position in The Cigna Group during the fourth quarter valued at approximately $29,000. Fairfield Bush & CO. acquired a new position in The Cigna Group during the second quarter valued at approximately $28,000. Finally, VisionPoint Advisory Group LLC boosted its position in The Cigna Group by 112.2% during the third quarter. VisionPoint Advisory Group LLC now owns 104 shares of the health services provider’s stock valued at $30,000 after purchasing an additional 55 shares during the last quarter. 86.99% of the stock is currently owned by institutional investors.

Insiders Place Their Bets

In other The Cigna Group news, SVP Hoeltzel Mary T. Agoglia sold 4,867 shares of the firm’s stock in a transaction on Wednesday, February 7th. The stock was sold at an average price of $330.48, for a total transaction of $1,608,446.16. Following the transaction, the senior vice president now owns 2,102 shares in the company, valued at approximately $694,668.96. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. In other news, CEO David Cordani sold 31,209 shares of The Cigna Group stock in a transaction on Monday, March 25th. The stock was sold at an average price of $355.17, for a total value of $11,084,500.53. Following the transaction, the chief executive officer now owns 348,054 shares in the company, valued at approximately $123,618,339.18. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, SVP Hoeltzel Mary T. Agoglia sold 4,867 shares of The Cigna Group stock in a transaction on Wednesday, February 7th. The shares were sold at an average price of $330.48, for a total value of $1,608,446.16. Following the completion of the transaction, the senior vice president now owns 2,102 shares in the company, valued at approximately $694,668.96. The disclosure for this sale can be found here. Insiders have sold a total of 114,144 shares of company stock worth $39,296,330 in the last 90 days. Company insiders own 0.60% of the company’s stock.

The Cigna Group Stock Performance

Shares of NYSE CI traded up $3.76 during trading hours on Thursday, reaching $349.84. 683,680 shares of the stock were exchanged, compared to its average volume of 1,593,229. The firm has a market capitalization of $102.28 billion, a price-to-earnings ratio of 19.89, a P/E/G ratio of 1.06 and a beta of 0.56. The company has a debt-to-equity ratio of 0.61, a quick ratio of 0.67 and a current ratio of 0.67. The Cigna Group has a 52 week low of $240.50 and a 52 week high of $365.71. The stock’s fifty day simple moving average is $347.73 and its 200 day simple moving average is $314.79.

The Cigna Group (NYSE:CI) last posted its quarterly earnings data on Friday, February 2nd. The health services provider reported $6.79 EPS for the quarter, topping analysts’ consensus estimates of $6.54 by $0.25. The Cigna Group had a return on equity of 13.59% and a net margin of 2.64%. The firm had revenue of $51.15 billion for the quarter, compared to analyst estimates of $48.91 billion. During the same quarter last year, the company earned $4.96 EPS. The company’s revenue was up 11.8% on a year-over-year basis. Sell-side analysts predict that The Cigna Group will post 28.36 EPS for the current year.

The Cigna Group Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Thursday, March 21st. Shareholders of record on Wednesday, March 6th were paid a dividend of $1.40 per share. This represents a $5.60 dividend on an annualized basis and a yield of 1.60%. The ex-dividend date was Tuesday, March 5th. This is a positive change from The Cigna Group’s previous quarterly dividend of $1.23. The Cigna Group’s dividend payout ratio (DPR) is 32.20%.

Wall Street Analysts Forecast Growth

Several research analysts recently commented on CI shares. Deutsche Bank Aktiengesellschaft raised The Cigna Group from a “hold” rating to a “buy” rating and increased their price target for the company from $355.00 to $370.00 in a research report on Thursday, February 1st. Wells Fargo & Company increased their price target on The Cigna Group from $334.00 to $348.00 and gave the company an “equal weight” rating in a research report on Tuesday, February 6th. Oppenheimer reissued an “outperform” rating and set a $360.00 price target on shares of The Cigna Group in a research report on Wednesday, January 17th. Cantor Fitzgerald reissued an “overweight” rating and set a $384.00 price target on shares of The Cigna Group in a research report on Wednesday, April 10th. Finally, Sanford C. Bernstein raised The Cigna Group from a “market perform” rating to an “outperform” rating and raised their price objective for the company from $330.00 to $372.00 in a research report on Thursday, January 4th. Two analysts have rated the stock with a hold rating, ten have assigned a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Buy” and a consensus target price of $362.14.

The Cigna Group Company Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.